-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
in Medicine |
|
Submit your manuscript
Scope
Infectious Diseases - Surveillance, Prevention and Treatment is a specialty section of Frontiers in Medicine and Frontiers in Public Health that provides an interactive forum to open new perspectives and publish research advances that unravel the mechanisms and determinants of human infections, including host-pathogen interactions and microbial pathogen adaptation at patient and population levels, and translate this knowledge into innovative diagnostic, therapeutic and preventative interventions.
Scope
Medicine and public health are facing the ever more complex and disruptive threats of emerging infectious diseases and antimicrobial drug resistance dissemination in a globalised world. Interdisciplinary approaches are key to the understanding, assessment and management of these health threats. This section on “Infectious Diseases – Surveillance, Prevention and Treatment” in Frontiers in Medicine and Frontiers in Public Health provides an interactive forum to open new perspectives and publish research advances that unravel the mechanisms and determinants of human infections, including host-pathogen interactions and microbial pathogen adaptation at patient and population levels, and translate this knowledge into innovative diagnostic, therapeutic and preventative interventions.
This section aims to strengthen the evidence base to inform clinical and public health practice and to improve the effectiveness of infectious disease detection, surveillance, management and control. Areas of particular interest include observational and interventional studies of emerging infectious diseases, healthcare-associated infections and infections in compromised hosts and vulnerable communities. Advances in molecular and genomic epidemiology investigations and surveillance of viral, bacterial, fungal and parasitic infections in humans are considered of great interest. Studies deciphering the emergence and spread of antimicrobial drug resistance and evaluating novel control strategies to contain drug resistance, including antimicrobial stewardship and health system change, are also welcome.
Emphasis is given to trans-disciplinary approaches and integrative precision methods such as omics-based diagnostics and genomics based surveillance and control of infection and drug resistance. This section also encourages submissions of clinical trial reports and quasi-experimental healthcare intervention studies on novel diagnostics, anti-infective therapeutics and personalised care pathways. It will also consider reports of implementation studies on public health interventions to prevent infectious diseases, including vaccine effectiveness and immunisation policies evaluation.
The section encourages authors to consult relevant scientific reporting guidelines, such as CONSORT, STROBE, STARD, PRISMA, and their specific infectious disease elaborations such as STROME-ID, STROBE-AMS, STROBE-NI, and ORION Statement (see equator-network.org) while preparing their manuscripts.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Infectious Diseases – Surveillance, Prevention and Treatment welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Clinical Trial, Correction, Editorial, Erratum, Focused Review, Frontiers Commentary, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Infectious Diseases – Surveillance, Prevention and Treatment, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Infectious Diseases – Surveillance, Prevention and Treatment will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine and Public Health.
Frontiers Editorial Office
EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01